DHRS9 is also implicated in the biosynthesis of all-trans-retinoic acid (atRA), which is the most active retinoid metabolite and contributes to the suppression of CRC progression through cell growth inhibition and cell differentiation induction (13). The gene discussed is DHRS9; the disease is colorectal carcinoma.